Volume 11, Issue 12 (February 2018)
Qom Univ Med Sci J 2018, 11(12): 17-24 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Soltani H, Salouti M, Shokri R. The Antifungal Effect of Silver, Copper Nanoparticles, and Their Combination and in combination with Amphotericin B against Candida albicans In Vitro and in Animal Model. Qom Univ Med Sci J 2018; 11 (12) :17-24
URL: http://journal.muq.ac.ir/article-1-1438-en.html
URL: http://journal.muq.ac.ir/article-1-1438-en.html
1- Department of Microbiology, Faculty of Sciences, Zanjan Branch, Islamic Azad University, Zanjan, Iran.
2- Biology Research Center, Zanjan Branch, Islamic Azad University, Zanjan, Iran. ,saloutim@yahoo.com
2- Biology Research Center, Zanjan Branch, Islamic Azad University, Zanjan, Iran. ,
Abstract: (5973 Views)
Background and Objectives: Candida is a genus of yeasts and is considered as the most common cause of fungal infections in the medical world. In this research, the antifungal activity of silver nanoparticles, copper nanoparticles, and their combination and with amphotericin B, was investigated in order to produce an effective antimicrobial drug against against infections caused by Candida albicans.
Methods: In this experimental study, the minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) for silver nanoparticles, copper nanoparticles, and their combination form and in combination with amphotericin B, was performed based on microdilution method. Then, their antifungal effect was investigated in infected mouse model.
Results: MIC and MFC of silver nanoparticles for Candida albicans were, respectively, 8 ppm and 15.50 ppm, of copper nanoparticles were 62.50ppm and 125 ppm, and of their combination form were 31 ppm and 62.50 ppm. MIC and MFC of silver nanoparticles in combination with amphotericin B for Candida albicans were, respectively, 15.50ppm and 31ppm, and for the combination of copper nanoparticles and amphotericin B against Candida albicans was obtained 8ppm and 15.50ppm. The mouse model study confirmed the antifungal effect of the nanoparticles against Candida albicans; so that silver nanoparticles, copper nanoparticles, and their combination showed the highest antifungal effect, and combination of silver or copper nanoparticles with amphotericin B had the lowest antifungal effect in the animal model.
Conclusion: The results showed that silver, copper nanoparticles, and their combination form have higher antimicrobial effect compared to antifungal amphotericin B.
Methods: In this experimental study, the minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) for silver nanoparticles, copper nanoparticles, and their combination form and in combination with amphotericin B, was performed based on microdilution method. Then, their antifungal effect was investigated in infected mouse model.
Results: MIC and MFC of silver nanoparticles for Candida albicans were, respectively, 8 ppm and 15.50 ppm, of copper nanoparticles were 62.50ppm and 125 ppm, and of their combination form were 31 ppm and 62.50 ppm. MIC and MFC of silver nanoparticles in combination with amphotericin B for Candida albicans were, respectively, 15.50ppm and 31ppm, and for the combination of copper nanoparticles and amphotericin B against Candida albicans was obtained 8ppm and 15.50ppm. The mouse model study confirmed the antifungal effect of the nanoparticles against Candida albicans; so that silver nanoparticles, copper nanoparticles, and their combination showed the highest antifungal effect, and combination of silver or copper nanoparticles with amphotericin B had the lowest antifungal effect in the animal model.
Conclusion: The results showed that silver, copper nanoparticles, and their combination form have higher antimicrobial effect compared to antifungal amphotericin B.
Type of Study: Original Article |
Subject:
قارچ شناسی
Received: 2017/01/21 | Accepted: 2017/05/13 | Published: 2018/02/19
Received: 2017/01/21 | Accepted: 2017/05/13 | Published: 2018/02/19
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Owned by Qom University of Medical Sciences
Published by Qom University of Medical Sciences Press
eISSN: 2008-1375
pISSN: 1735-7799
Email: journal[at]muq.ac.ir
j.mua.ac[at]gmail.com
